Scientific Literature Search

Source record

Odor identification and progression of parkinsonian signs in older persons.

Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA.

Exp Aging Res · 2008-07-01

DOI: 10.1080/03610730802070001PMID: 18568978

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Caffeine and progression of Parkinson disease.

Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC, NET-D Investigators.

Clin Neuropharmacol · 2008-07-01

DOI: 10.1097/wnf.0b013e31815a3f03PMID: 18670242

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.

Schiess M, Oh I.

Arch Neurol · 2008-06-01

DOI: 10.1001/archneur.65.6.698PMID: 18541788

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.

Wright AK, Miller C, Williams M, Arbuthnott G.

Brain Res · 2008-04-18

DOI: 10.1016/j.brainres.2008.04.020PMID: 18495090

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Parkinson Study Group PRECEPT Investigators, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J.

Arch Neurol · 2008-04-14

DOI: 10.1001/archneur.2008.65.6.nct70003PMID: 18413464

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clarifying the pathological progression of Parkinson's disease.

Halliday G.

Acta Neuropathol · 2008-04-01

DOI: 10.1007/s00401-008-0353-7PMID: 18299858

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A not entirely benign procedure: progression of Parkinson's disease.

Del Tredici K, Braak H.

Acta Neuropathol · 2008-04-01

DOI: 10.1007/s00401-008-0355-5PMID: 18320198

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Protection against Parkinson's disease progression: clinical experience.

LeWitt PA, Taylor DC.

Neurotherapeutics · 2008-04-01

DOI: 10.1016/j.nurt.2008.01.007PMID: 18394564

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clinical features at first visit and rapid disease progression in Parkinson's disease.

Ferguson LW, Rajput ML, Muhajarine N, Shah SM, Rajput A.

Parkinsonism Relat Disord · 2008-03-05

DOI: 10.1016/j.parkreldis.2007.10.012PMID: 18321757

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Animal models of Parkinson's disease progression.

Meredith GE, Sonsalla PK, Chesselet MF.

Acta Neuropathol · 2008-02-14

DOI: 10.1007/s00401-008-0350-xPMID: 18273623

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, de Klerk O, van Oostrom JC, Portman A, Leenders KL.

J Neural Transm (Vienna) · 2008-02-12

DOI: 10.1007/s00702-008-0030-yPMID: 18265929

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mortalin: a protein associated with progression of Parkinson disease?

Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, Gearing M, Pan C, Zhang J.

J Neuropathol Exp Neurol · 2008-02-01

DOI: 10.1097/nen.0b013e318163354aPMID: 18219256

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

1.402 articles found

Odor identification and progression of parkinsonian signs in older persons.

Caffeine and progression of Parkinson disease.

Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.

Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

Clarifying the pathological progression of Parkinson's disease.

A not entirely benign procedure: progression of Parkinson's disease.

Protection against Parkinson's disease progression: clinical experience.

Clinical features at first visit and rapid disease progression in Parkinson's disease.

Animal models of Parkinson's disease progression.

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

Mortalin: a protein associated with progression of Parkinson disease?

Filters